Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.
about
Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balanceDo selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials.Lumiracoxib in the management of osteoarthritis and acute pain.Accounting for the increase in NSAID expenditure: substitution or leakage?Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxibAn evidence-based update on nonsteroidal anti-inflammatory drugs.Efficacy of lumiracoxib in osteoarthritis: a review of nine studies.The safety of lumiracoxib when used in the treatment of arthritis.Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor.Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.Cardiovascular risks of cyclooxygenase inhibition.Amtolmetin: A Reappraisal of NSAID with Gastroprotection.New insights into eicosanoid biosynthetic pathways: implications for arthritis.Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.WITHDRAWN: Celecoxib for rheumatoid arthritis.Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses.Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis.Lumiracoxib, a highly selective COX-2 inhibitor.Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores.Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal ToxicityCelecoxib for rheumatoid arthritis
P2860
Q28191924-418EEA11-1FB4-4F2C-8834-02A07EF2FC37Q34592340-57981FBA-464C-4C00-81C2-AFCB9078591CQ34657320-FCF4AC0C-F3C6-4A31-8F46-34AD2F70F120Q34768089-3917F87C-09B8-45D5-8341-C6ECFDA65885Q35553447-DC0E0B83-0BBB-4089-AFA4-0B9D4728988BQ35758411-4B5B07BE-538E-427D-B305-ED62902C60E7Q36009834-EDA4F7E2-5A17-4669-8E1D-69EE2616B3B4Q36066121-636D11A3-AABB-4B90-8742-5AA3AACB6899Q36120809-FB21E3BF-9858-419D-BBE8-EFB2CCD085B7Q36195392-5766B917-AF54-48F2-9DC1-2F7C4A6025EEQ36520638-652C1E80-83B1-4C62-9C05-CB21019C06C9Q36764647-32F9908D-3266-47FA-B517-5132B0C67290Q37754734-FA01483F-B182-4122-8F38-15AF7C0C27B2Q37893966-51691569-D33A-4214-A6C3-A65192ABBB87Q38734238-0F2D875F-6671-4119-ACE5-5A9B0C2EF1C5Q38962092-B94E93F4-A220-4355-95DA-FC7621158F50Q38993297-82B0ECFE-D820-4D99-A7E9-3121C44EFEFEQ41715750-560914C8-0BF5-43D5-9D3A-A31E24AD4934Q43061570-9010EE51-44E8-47A5-8E9D-E9CB8A7088E3Q53060894-47F5478F-E236-4B6C-87A2-ABF66DF75717Q57169425-8932A56F-7B66-4593-B435-66914E7AB696Q57318857-03171AE6-0979-4A62-99FF-422D7382012D
P2860
Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@ast
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@en
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@nl
type
label
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@ast
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@en
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@nl
prefLabel
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@ast
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@en
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P1476
Reduced incidence of gastroduo ...... nts with rheumatoid arthritis.
@en
P2093
A J Kivitz
H J Thurston
S Nayiager
T Schimansky
P2860
P304
P356
10.1111/J.1365-2036.2004.01956.X
P407
P577
2004-06-01T00:00:00Z